Higher serum progesterone level has no negative impact on live birth rate in frozen embryo transfer

IF 2.1 4区 医学 Q2 OBSTETRICS & GYNECOLOGY European journal of obstetrics, gynecology, and reproductive biology Pub Date : 2024-10-09 DOI:10.1016/j.ejogrb.2024.10.011
Mauro Cozzolino , Irene Hervás , Yagmur Ergun , Maria Giulia Massaro , Nuria Pellicer , Franco de Angelis , Elena Labarta , Daniela Galliano
{"title":"Higher serum progesterone level has no negative impact on live birth rate in frozen embryo transfer","authors":"Mauro Cozzolino ,&nbsp;Irene Hervás ,&nbsp;Yagmur Ergun ,&nbsp;Maria Giulia Massaro ,&nbsp;Nuria Pellicer ,&nbsp;Franco de Angelis ,&nbsp;Elena Labarta ,&nbsp;Daniela Galliano","doi":"10.1016/j.ejogrb.2024.10.011","DOIUrl":null,"url":null,"abstract":"<div><div>Optimal synchronisation between the endometrium and the embryo is key to the success of frozen embryo transfers (FET). It is achieved by administering different doses of exogenous oestrogen and progesterone (P4). The negative impact of low levels of P4 on FET has been reported, but there is a lack of knowledge about which levels are most appropriate. We aimed to evaluate whether high serum P4 levels measured on FET day affect the probability of having a baby at home. This retrospective cohort study includes 7546 FET cycles performed with hormone replacement therapy (HRT) for artificial endometrial preparation. Patients were divided into three groups according to P level on FET day (ng/mL): P4 &lt; 20(n = 6623), P4 ≥ 20–40 (n = 770) and P &gt; 40 (n = 146). Female age was per group P4 &lt; 20 = 38.7 ± 3.1, P ≥ 20–40 = 39.0 ± 3.0, and P4 &gt; 40 = 38.1 ± 2.9 years old (p = 0.53). The group with the highest progesterone levels found lower ongoing pregnancy rates without statistical significance (56.3 % (P4 &lt; 20) vs 56.8 % (P4 ≥ 20-&lt;40) vs 51.4 % (P4 &gt; 40); p = 0.5). Miscarriage rate was also higher, although not significantly: 16.2 % (P4 &lt; 20) vs 15.0 % (P4 ≥ 20-&lt;40) vs 18.0 % (P4 &gt; 40) (p = 0.6). These findings were explored with an adjusted analysis. A higher, but not significant, odds of miscarriage was observed when P4 &gt; 40 ng/ml, aOR = 1.14 (0.75–1.74) (p = 0.55) whereas no such association was found with P4 ≥ 20–40 ng/ml (aOR = 0.92 (0.74–1.15) (p = 0.46)). The probability of livebirth is similar when the patient was P4 &gt; 40 (aOR = 0.77 (0.51–1.15) (p = 0.20)) than when P4 ≥ 20-&lt;40 (aOR = 0.94 (0.79–1.11) (p = 0.47). In conclusion, women with elevated serum P4 levels on the day of FET after HRT do not find their probability of live birth impaired.</div></div>","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"303 ","pages":"Pages 15-21"},"PeriodicalIF":2.1000,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of obstetrics, gynecology, and reproductive biology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0301211524005499","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Optimal synchronisation between the endometrium and the embryo is key to the success of frozen embryo transfers (FET). It is achieved by administering different doses of exogenous oestrogen and progesterone (P4). The negative impact of low levels of P4 on FET has been reported, but there is a lack of knowledge about which levels are most appropriate. We aimed to evaluate whether high serum P4 levels measured on FET day affect the probability of having a baby at home. This retrospective cohort study includes 7546 FET cycles performed with hormone replacement therapy (HRT) for artificial endometrial preparation. Patients were divided into three groups according to P level on FET day (ng/mL): P4 < 20(n = 6623), P4 ≥ 20–40 (n = 770) and P > 40 (n = 146). Female age was per group P4 < 20 = 38.7 ± 3.1, P ≥ 20–40 = 39.0 ± 3.0, and P4 > 40 = 38.1 ± 2.9 years old (p = 0.53). The group with the highest progesterone levels found lower ongoing pregnancy rates without statistical significance (56.3 % (P4 < 20) vs 56.8 % (P4 ≥ 20-<40) vs 51.4 % (P4 > 40); p = 0.5). Miscarriage rate was also higher, although not significantly: 16.2 % (P4 < 20) vs 15.0 % (P4 ≥ 20-<40) vs 18.0 % (P4 > 40) (p = 0.6). These findings were explored with an adjusted analysis. A higher, but not significant, odds of miscarriage was observed when P4 > 40 ng/ml, aOR = 1.14 (0.75–1.74) (p = 0.55) whereas no such association was found with P4 ≥ 20–40 ng/ml (aOR = 0.92 (0.74–1.15) (p = 0.46)). The probability of livebirth is similar when the patient was P4 > 40 (aOR = 0.77 (0.51–1.15) (p = 0.20)) than when P4 ≥ 20-<40 (aOR = 0.94 (0.79–1.11) (p = 0.47). In conclusion, women with elevated serum P4 levels on the day of FET after HRT do not find their probability of live birth impaired.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
较高的血清孕酮水平对冷冻胚胎移植的活产率没有负面影响
子宫内膜与胚胎之间的最佳同步是冷冻胚胎移植(FET)成功的关键。它是通过施用不同剂量的外源性雌激素和孕酮(P4)来实现的。有报道称,低水平的 P4 会对 FET 产生负面影响,但目前还不清楚哪种水平的 P4 最合适。我们的目的是评估在 FET 日测量到的高血清 P4 水平是否会影响在家分娩的概率。这项回顾性队列研究包括 7546 例使用激素替代疗法(HRT)进行人工子宫内膜准备的 FET 周期。根据 FET 日的 P 水平(纳克/毫升)将患者分为三组:P4 < 20(n = 6623)、P4 ≥ 20-40(n = 770)和 P > 40(n = 146)。每组女性年龄为 P4 < 20 = 38.7 ± 3.1 岁,P≥ 20-40 = 39.0 ± 3.0 岁,P4 > 40 = 38.1 ± 2.9 岁(P = 0.53)。孕酮水平最高的一组的持续妊娠率较低,但无统计学意义(56.3%(P4 <20) vs 56.8%(P4 ≥ 20-<40) vs 51.4%(P4 >40);P = 0.5)。流产率也较高,但不明显:16.2% (P4 < 20) vs 15.0% (P4 ≥ 20-<40) vs 18.0% (P4 > 40) (p = 0.6)。对这些结果进行了调整分析。当 P4 > 40 ng/ml 时,观察到流产几率较高,但并不显著,aOR = 1.14 (0.75-1.74) (p = 0.55),而 P4 ≥ 20-40 ng/ml 时则没有发现这种关联(aOR = 0.92 (0.74-1.15) (p = 0.46))。与 P4≥20-<40 时(aOR = 0.94 (0.79-1.11) (p = 0.47))相比,P4 > 40 时(aOR = 0.77 (0.51-1.15) (p = 0.20))的活产概率相似。总之,HRT 后 FET 当日血清 P4 水平升高的妇女不会影响其活产概率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.60
自引率
3.80%
发文量
898
审稿时长
8.3 weeks
期刊介绍: The European Journal of Obstetrics & Gynecology and Reproductive Biology is the leading general clinical journal covering the continent. It publishes peer reviewed original research articles, as well as a wide range of news, book reviews, biographical, historical and educational articles and a lively correspondence section. Fields covered include obstetrics, prenatal diagnosis, maternal-fetal medicine, perinatology, general gynecology, gynecologic oncology, uro-gynecology, reproductive medicine, infertility, reproductive endocrinology, sexual medicine and reproductive ethics. The European Journal of Obstetrics & Gynecology and Reproductive Biology provides a forum for scientific and clinical professional communication in obstetrics and gynecology throughout Europe and the world.
期刊最新文献
Maternal and perinatal outcomes following code red cesarean delivery performed among hospitals with different level of care. Case-control study of clotting differences using ROTEM testing in pregnant patients with early vaginal bleeding. Corrigendum to "Mode of delivery predicts postpartum maternal leukocyte telomere length" [Eur. J. Obstetr. Gynecol. Reprod. Biol. 300 (2024) 224-229]. Corrigendum to “Recombinant-Luteinzing hormone supplementation in women during IVF/ICSI cycles with GnRH-antagonist protocol: A systematic review and meta-analysis” [Eur. J. Obstet. Gynecol. Reprod. Biol. 283 (2023) 43–48] Comparative study on the effects of combined oral contraceptives and dienogest in women with endometriosis‑associated chronic pelvic pain
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1